New York Times Company (The) (NYT) is currently trading at $72.99. Based on 9 Wall Street analysts, the average target price is $83.44, implying a 14.3% upside. The consensus recommendation is NONE.

NYT

New York Times Company (The)

Communication ServicesOpinion: none

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$72.99

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

LowHigh
$66.00$92.00
Current $72.99
Median: $80.00Mean: $78.00Current: $72.99

Recent price target updates (latest 80)

  • B of A SecuritiesJun 24, 2026

    PT action: Lowers

    $87.00 → $80.00

  • JP MorganMay 29, 2026

    PT action: Raises

    $74.00 → $82.00

  • BarclaysMay 7, 2026

    PT action: Raises

    $60.00 → $66.00

  • GuggenheimMay 7, 2026

    PT action: Raises

    $63.00 → $70.00

  • Evercore ISI GroupMay 7, 2026

    PT action: Raises

    $75.00 → $92.00

  • B of A SecuritiesApr 22, 2026

    PT action: Announces

    $0.00 → $84.00

  • CitigroupMar 24, 2026

    PT action: Raises

    $77.00 → $94.00

  • CitigroupFeb 5, 2026

    PT action: Lowers

    $81.00 → $77.00

  • JP MorganFeb 5, 2026

    PT action: Raises

    $71.00 → $74.00

  • Evercore ISI GroupFeb 5, 2026

    PT action: Raises

    $69.00 → $75.00

  • BarclaysJan 20, 2026

    PT action: Raises

    $55.00 → $60.00

  • CitigroupDec 23, 2025

    PT action: Raises

    $72.00 → $81.00

  • CitigroupNov 13, 2025

    PT action: Raises

    $64.00 → $72.00

  • JP MorganNov 6, 2025

    PT action: Raises

    $70.00 → $71.00

  • Morgan StanleyNov 6, 2025

    PT action: Raises

    $59.00 → $62.00

  • BarclaysNov 6, 2025

    PT action: Raises

    $52.00 → $55.00

  • Evercore ISI GroupAug 8, 2025

    PT action: Raises

    $60.00 → $67.00

  • Morgan StanleyAug 7, 2025

    PT action: Raises

    $54.00 → $59.00

  • JP MorganAug 7, 2025

    PT action: Raises

    $62.00 → $70.00

  • GuggenheimAug 7, 2025

    PT action: Raises

    $55.00 → $56.00

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$83.44

Based on 9 analysts

Analyst Recommendations

Buy (6)Hold (4)Sell (0)

Upside

+14.32%

Market Cap

$0.00B

Financial & Investment Metrics

P/E Ratio (TTM)31.33
Forward P/E22.69
P/B Ratio5.87
Dividend Yield1.23%
Return on Equity (ROE)19.68%
Operating Margin13.13%
Debt to Equity2.39
Beta (Volatility)0.95
52 Week Range$51.03 - $87.10
LowCurrent: $72.99High

Latest News

Daily editorial mentioning NYT

Price target moves

Citigroup Reshuffles Materials as FDX Sees Mixed Target Adjustments

The latest round of Wall Street revisions, as of June 25, 2026, highlights a distinct divergence in sentiment within the Materials sector. While Citigroup analysts have been busy adjusting their outlooks, the activity reflects a broader, more surgical approach to valuation that has spilled over into Industrials and Healthcare.

Who moved targets

Citigroup led the charge with a flurry of activity in the Materials space. They raised price targets on SHW to 380 from 355, alongside upward adjustments for PPG (114 to 125), LIN (585 to 600), and ECL (325 to 330). However, the firm simultaneously took a more cautious stance on other industry constituents, slashing targets for IFF, LYB, DOW, and CE. The most significant of these downward revisions was Celanese (CE), which saw its target cut from 80 to 68.

Elsewhere, FedEx (FDX) remains a point of contention among analysts. While Citigroup and B of A Securities issued modest target increases—moving the stock to 359 and 378 respectively—Stifel and UBS opted for substantial downward revisions, pulling their targets back to 326 and 350. This creates a wide variance in how the street views the logistics giant’s near-term trajectory.

Ticker Firm Dir Prior→Current
SHW Citigroup Up 355 → 380
CE Citigroup Down 80 → 68
FDX Stifel Down 442 → 326
BSX Jefferies Down 100 → 67

Reading the revisions

The contrast between the bullish upgrades in Materials and the aggressive downgrades elsewhere is striking. For instance, Jefferies issued a sharp reduction for Boston Scientific (BSX), dropping the target from 100 to 67, a move that starkly contrasts with the steady, incremental upgrades seen in the Financials sector. Within that group, Truist Securities pushed AXP to 375, while Piper Sandler nudged MET up to 90 (an 8.7% implied upside).

These revisions often serve as a reaction to underlying operational shifts rather than just macro sentiment. It is worth tracking these market moves to see if the downward pressure on firms like DOW and LYB—which now show implied upsides of 43.8% and 43.2% respectively—triggers a bottom-fishing response from the broader market. When a firm like Citigroup downgrades a name while simultaneously flagging a large implied upside, it suggests that while the target has been lowered, the valuation may still be viewed as disconnected from the current market price. Monitoring these gaps provides a clearer picture of where analysts are losing patience versus where they are simply recalibrating for volatility.

Read article

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 0Insider Sells: 10

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
6/3/2026WELCH JACQUELINE MOfficerSale at price 74.14 per share.4,000
5/12/2026KOPIT LEVIEN MEREDITH AChief Executive OfficerSale at price 78.00 per share.9,750
5/12/2026BARDEEN WILLIAMChief Financial OfficerSale at price 77.85 per share.4,121
5/11/2026PERPICH DAVID SDirectorSale at price 77.06 per share.9,000
3/3/2026KOPIT LEVIEN MEREDITH AChief Executive OfficerSale at price 79.70 per share.51,949
3/3/2026SULZBERGER ARTHUR GREGGChairman of the BoardSale at price 79.95 per share.13,000
3/3/2026BARDEEN WILLIAMChief Financial OfficerSale at price 79.56 per share.13,000
2/20/2026BRAYTON DIANEOfficerSale at price 77.03 per share.4,600
2/17/2026BENTEN ROBERT ANTHONYOfficer and TreasurerSale at price 73.57 per share.1,913
11/6/2025KOPIT LEVIEN MEREDITH AChief Executive OfficerSale at price 59.68 per share.16,972

Frequently Asked Questions

Q. What is the current target price and upside for NYT?

A. The current target price for New York Times Company (The) is $83.44, which implies a 14.3% upside from the current price of $72.99. This is based on the consensus of 9 Wall Street analysts.

Q. What is the current analyst recommendation for NYT?

A. Currently, there are 1 Strong Buy, 5 Buy, 4 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is NONE.

Q. Are insiders buying NYT stock recently?

A. Over the past 6 months, there have been 0 insider buys and 10 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Communication Services

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer